Clene Inc Insiders
| CLNNWDelisted Stock | USD 0 0.0004 18.18% |
Clene employs about 75 people. The company is managed by 10 executives with a total tenure of roughly 175 years, averaging almost 17.0 years of service per executive, having 7.5 employees per reported executive. Recap of Clene's management performance can provide insight into the venture performance.
Clene |
Clene Management Team Effectiveness
The company has return on total asset (ROA) of (0.5624) % which means that it has lost $0.5624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.3836) %, meaning that it generated substantial loss on money invested by shareholders. Clene's management efficiency ratios could be used to measure how well Clene manages its routine affairs as well as how well it operates its assets and liabilities.Some institutional investors establish a significant position in stocks such as Clene in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Clene, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Clene Workforce Comparison
Clene Inc is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 199. Clene totals roughly 75.0 in number of employees claiming about 38% of equities under Health Care industry.
Clene Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Clene insiders, such as employees or executives, is commonly permitted as long as it does not rely on Clene's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Clene insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ugwumba Chidozie over three weeks ago Disposition of 41 shares by Ugwumba Chidozie of Clene at 5.08 subject to Rule 16b-3 | ||
Ugwumba Chidozie over three weeks ago Disposition of 6418 shares by Ugwumba Chidozie of Clene at 5.02 subject to Rule 16b-3 | ||
Rob Etherington over a month ago Acquisition by Rob Etherington of 75000 shares of Clene at 5.42 subject to Rule 16b-3 | ||
Ugwumba Chidozie over a month ago Disposition of 12119 shares by Ugwumba Chidozie of Clene at 5.05 subject to Rule 16b-3 | ||
Ugwumba Chidozie over a month ago Disposition of 7923 shares by Ugwumba Chidozie of Clene at 5.13 subject to Rule 16b-3 | ||
Ugwumba Chidozie over a month ago Disposition of 12563 shares by Ugwumba Chidozie of Clene at 5.1 subject to Rule 16b-3 | ||
Ugwumba Chidozie over a month ago Disposition of 19621 shares by Ugwumba Chidozie of Clene at 5.12 subject to Rule 16b-3 | ||
Ugwumba Chidozie over a month ago Disposition of 3111 shares by Ugwumba Chidozie of Clene at 6.04 subject to Rule 16b-3 |
Clene Notable Stakeholders
A Clene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Clene often face trade-offs trying to please all of them. Clene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Clene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert MBA | President CEO | Profile | |
| Robert MD | Chief Officer | Profile | |
| Jeong Ted | Chief Officer | Profile | |
| Mark ESQ | Chief Officer | Profile | |
| Michael Hotchkin | Chief Officer | Profile | |
| Rob Etherington | Pres CEO | Profile | |
| Mark Mortenson | CoFounder Officer | Profile | |
| Mary Mcneil | Head Resources | Profile | |
| MHS MD | Head Medical | Profile | |
| Jerry JD | General Secretary | Profile |
About Clene Management Performance
The success or failure of an entity such as Clene Inc often depends on how effective the management is. Clene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Clene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Clene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of various therapeutics for neurodegenerative diseases. The companys products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing and NM-PtAu7, a gold-platinum CSN therapeutic. Clene Inc is traded on NASDAQ Exchange in the United States.
Please note, the imprecision that can be found in Clene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Clene Inc. Check Clene's Beneish M Score to see the likelihood of Clene's management manipulating its earnings.
Clene Workforce Analysis
Traditionally, organizations such as Clene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Clene within its industry.Clene Manpower Efficiency
Return on Clene Manpower
| Revenue Per Employee | 4.6K | |
| Revenue Per Executive | 34.2K | |
| Net Loss Per Employee | 525.3K | |
| Net Loss Per Executive | 3.9M | |
| Working Capital Per Employee | 78.2K | |
| Working Capital Per Executive | 586.6K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Clene Stock
If you are still planning to invest in Clene Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clene's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |